Amount Raised
€870,000
Round Type
Seed
HerpenPharmaceutical ManufacturingDescription
Dutch-based Orexa raises €870K from new and existing investors to fund two phase 2 clinical trials further, aiming to increase food intake for patients who have undergone surgery, anorexia patients, and older adults with malnutrition.
Quick answer
Orexa raised €870,000 in a Seed round, dated February 2, 2024. Orexa is based in Herpen, North Brabant, Netherlands.
- How much did Orexa raise?
- Orexa raised €870,000 in a Seed round on February 2, 2024.
- What does Orexa do?
- Orexa is a phase 2 pharmaceutical company that develops and commercializes therapeutics to increase food intake.
- Where is Orexa based and how big is it?
- Orexa is based in Herpen, North Brabant, Netherlands.
Source: Fundz verified event record.
Who else raised in Pharmaceutical Manufacturing around the same time
Companies in the same sectors as Orexa that raised within 45 days of this round, from Fundz verified event records.
- Zeno Health raised $25M (Series C) on February 27, 2024.
- XORTX Therapeutics raised $2.5M (Seed) on February 19, 2024.
- COUR Pharmaceuticals raised $105M (Funding Round) on February 11, 2024.
- DUDE CHEM raised $6.5M (Funding Round) on February 7, 2024.
- COUR Pharmaceuticals raised $105M (Series A) on January 30, 2024.
- 3Daughters raised $2M (Seed) on January 22, 2024.
Who to call at Orexa, and when
A new round usually means Orexa is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Orexa raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Orexa, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Orexa. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Orexa raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Orexa raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.